Terms: = Colorectal cancer AND HRAS, K-ras, 3265, ENSG00000174775, HRAS1, RASH1, c-bas/has, P01112, N-ras AND Diagnosis
115 results:
1. KRAS Pathways: A Potential Gateway for cancer Therapeutics and Diagnostics.
Tripathi PK; Mittal KR; Jain N; Sharma N; Jain CK
Recent Pat Anticancer Drug Discov; 2024; 19(3):268-279. PubMed ID: 37038676
[TBL] [Abstract] [Full Text] [Related]
2. Long-term benefits for lower socioeconomic groups by improving bowel screening participation in South Australia: A modelling study.
Lal A; Gao L; Tan E; McCaffrey N; Roder D; Buckley E
PLoS One; 2022; 17(12):e0279177. PubMed ID: 36542644
[TBL] [Abstract] [Full Text] [Related]
3. The utility of the Ion Torrent PGM next generation sequencing for analysis of the most commonly mutated genes among patients with colorectal cancer in India.
Mehra S; Tiwari AK; Mehta SP; Sachdev R; Rajvanshi C; Chauhan R; Saini A; Vaid A
Indian J Cancer; 2022; 59(2):218-222. PubMed ID: 33753628
[TBL] [Abstract] [Full Text] [Related]
4. Development of a panel of serum IgG and IgA autoantibodies for early diagnosis of colon cancer.
Chen M; Lin X; Zhang L; Yu L; Wu Q; Zhang S; Xue F; Huang Y
Int J Med Sci; 2020; 17(17):2744-2750. PubMed ID: 33162802
[No Abstract] [Full Text] [Related]
5. Detection and Characterization of Oncogene Mutations in Preneoplastic and Early Neoplastic Lesions.
Minamoto T
Methods Mol Biol; 2020; 2102():419-437. PubMed ID: 31989570
[TBL] [Abstract] [Full Text] [Related]
6. Pharmacological biotargets and the molecular mechanisms of oxyresveratrol treating colorectal cancer: Network and experimental analyses.
Li R; Song Y; Ji Z; Li L; Zhou L
Biofactors; 2020 Jan; 46(1):158-167. PubMed ID: 31647596
[TBL] [Abstract] [Full Text] [Related]
7. Comprehensive characterization of RAS mutations in colon and rectal cancers in old and young patients.
Serebriiskii IG; Connelly C; Frampton G; Newberg J; Cooke M; Miller V; Ali S; Ross JS; Handorf E; Arora S; Lieu C; Golemis EA; Meyer JE
Nat Commun; 2019 Aug; 10(1):3722. PubMed ID: 31427573
[TBL] [Abstract] [Full Text] [Related]
8. Partial response after treatment with Conversion chemotherapy: A case report of a patient with colon cancer and unresectable hepatic metastases.
Bu Z; Lu C; Yang X; Lai H; Jiang Y; Li Y; Lin Y; Qin Y; Xiao M; Cheng C; Liu Q
Medicine (Baltimore); 2019 Apr; 98(17):e15239. PubMed ID: 31027071
[TBL] [Abstract] [Full Text] [Related]
9. Development and validation of a novel prognostic score to predict survival in patients with metastatic colorectal cancer: the metastatic colorectal cancer score (mCCS).
Marschner N; Frank M; Vach W; Ladda E; Karcher A; Winter S; Jänicke M; Trarbach T
Colorectal Dis; 2019 Jul; 21(7):816-826. PubMed ID: 30834622
[TBL] [Abstract] [Full Text] [Related]
10. Critical Role of p53 and k-ras in the diagnosis of Early colorectal cancer: a One-year, Single-center Analysis.
Lu HY; Lin RT; Zhou GX; Yu TM; Liu ZJ
Int J Med Sci; 2017; 14(11):1154-1162. PubMed ID: 29104470
[No Abstract] [Full Text] [Related]
11. Molecular and Clinicopathological Differences by Age at the diagnosis of colorectal cancer.
Chang CC; Lin PC; Lin CC; Lan YT; Lin HH; Lin CH; Yang SH; Liang WY; Chen WS; Jiang JK; Lin JK; Chang SC
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28678173
[TBL] [Abstract] [Full Text] [Related]
12. Mutations in codons 12 and 13 of k-ras exon 2 in colorectal tumors of Saudi Arabian patients: frequency, clincopathological associations, and clinical outcomes.
Zekri J; Al-Shehri A; Mahrous M; Al-Rehaily S; Darwish T; Bassi S; El Taani H; Al Zahrani A; Elsamany S; Al-Maghrabi J; Sadiq BB
Genet Mol Res; 2017 Feb; 16(1):. PubMed ID: 28218784
[TBL] [Abstract] [Full Text] [Related]
13. Genetic Biomarker Prevalence Is Similar in Fecal Immunochemical Test Positive and Negative colorectal cancer Tissue.
Levin TR; Corley DA; Jensen CD; Marks AR; Zhao WK; Zebrowski AM; Quinn VP; Browne LW; Taylor WR; Ahlquist DA; Lidgard GP; Berger BM
Dig Dis Sci; 2017 Mar; 62(3):678-688. PubMed ID: 28044229
[TBL] [Abstract] [Full Text] [Related]
14. Histoprognostic markers role in colorectal cancer.
Bădulescu F; Mihai GM; Bădulescu A; Prejbeanu I
Rom J Morphol Embryol; 2016; 57(2):445-50. PubMed ID: 27516017
[TBL] [Abstract] [Full Text] [Related]
15. Human Blood Autoantibodies in the Detection of colorectal cancer.
Negm OH; Hamed MR; Schoen RE; Whelan RL; Steele RJ; Scholefield J; Dilnot EM; Shantha Kumara HM; Robertson JF; Sewell HF
PLoS One; 2016; 11(7):e0156971. PubMed ID: 27383396
[TBL] [Abstract] [Full Text] [Related]
16. [Insights on colorectal carcinoma based on the biological differences between left-sided and right- sided colon cancers].
Xu JM
Zhonghua Zhong Liu Za Zhi; 2016 May; 38(5):397-400. PubMed ID: 27188617
[TBL] [Abstract] [Full Text] [Related]
17. Associations between markers of colorectal cancer stem cells, mutation, microRNA and the clinical features of ulcerative colitis.
Yang L; Levi E; Du JH; Zhou HH; Miller R; Majumdar AP
Colorectal Dis; 2016 Jun; 18(6):O185-93. PubMed ID: 27153478
[TBL] [Abstract] [Full Text] [Related]
18. Prognostic significance of k-ras mutation rate in metastatic colorectal cancer patients.
Vincenzi B; Cremolini C; Sartore-Bianchi A; Russo A; Mannavola F; Perrone G; Pantano F; Loupakis F; Rossini D; Ongaro E; Bonazzina E; Dell'Aquila E; Imperatori M; Zoccoli A; Bronte G; De Maglio G; Fontanini G; Natoli C; Falcone A; Santini D; Onetti-Muda A; Siena S; Tonini G; Aprile G
Oncotarget; 2015 Oct; 6(31):31604-12. PubMed ID: 26384309
[TBL] [Abstract] [Full Text] [Related]
19. Factors affecting prognosis in metastatic colorectal cancer patients.
Eker B; Ozaslan E; Karaca H; Berk V; Bozkurt O; Inanc M; Duran AO; Ozkan M
Asian Pac J Cancer Prev; 2015; 16(7):3015-21. PubMed ID: 25854399
[TBL] [Abstract] [Full Text] [Related]
20. Selected case from the Arkadi M. Rywlin International Pathology Slide Club: carcinoma of the transverse colon in a young girl.
Galliani CA; Sanchez IC; D'Errico MM; Bisceglia M
Adv Anat Pathol; 2015 May; 22(3):217-24. PubMed ID: 25844680
[TBL] [Abstract] [Full Text] [Related]
[Next]